Natera Company Profile (NASDAQ:NTRA)

Analyst Ratings

Consensus Ratings for Natera (NASDAQ:NTRA) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.33 (39.95% upside)

Analysts' Ratings History for Natera (NASDAQ:NTRA)
Show:
DateFirmActionRatingPrice TargetActions
6/3/2016Cowen and CompanyReiterated RatingOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016Benchmark Co.Boost Price TargetBuy$15.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016Piper Jaffray Cos.Reiterated RatingOverweight$24.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016Robert W. BairdLower Price TargetOutperform$18.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/28/2015WedbushUpgradeNeutral -> Outperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2014 forward)

Earnings

Earnings History for Natera (NASDAQ:NTRA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016Q216($0.48)$50.64 millionListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/10/2016Q116($0.46)($0.17)$48.17 million$61.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415($0.64)($0.47)$45.26 million$52.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2015Q315($0.46)($0.39)$43.08 million$44.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2015($0.44)($0.40)$42.69 million$45.09 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Natera (NASDAQ:NTRA)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Natera (NASDAQ:NTRA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Natera (NASDAQ:NTRA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/6/2016Herm RosenmanCFOSell1,824$12.10$22,070.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2016Matthew RabinowitzCEOSell104,892$12.14$1,273,388.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2016Jonathan SheenaCTOSell188,442$11.94$2,249,997.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2016Matthew RabinowitzCEOSell732,831$11.94$8,750,002.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2016Roelof BothaDirectorBuy837,521$11.94$10,000,000.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2016Herm RosenmanCFOSell1,806$12.04$21,744.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Jonathan SheenaCTOSell10,000$8.03$80,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2016Matthew RabinowitzCEOSell54,683$10.37$567,062.71View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Jonathan SheenaCTOSell25,000$10.06$251,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2015Matthew RabinowitzCEOSell111,513$10.83$1,207,685.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2015Jonathan SheenaCTOSell50,000$10.44$522,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2015Matthew RabinowitzCEOSell83,804$10.62$889,998.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2015James HealyDirectorBuy350,000$18.00$6,300,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2015James HealyDirectorBuy400,000$22.81$9,124,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Natera (NASDAQ:NTRA)
DateHeadline
07/30/16 04:55 PMNew ACMG guidelines recommend NIPT as optimal initial screening test for all pregnant women
07/29/16 05:41 PMNatera : Announces Second Quarter Earnings Conference Call
07/29/16 03:08 PMStatement from the American College of Medical Genetics and Genomics Supports the Use of Non-Invasive Prenatal Testing for All Pregnant Women - [at noodls] - SAN CARLOS, Calif., July 29, 2016 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), (NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, applauds the new guidelines ...
07/28/16 06:38 PMNatera Announces Second Quarter Earnings Conference Call - [at noodls] - SAN CARLOS, Calif., July 28, 2016 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it will release ...
07/21/16 08:25 AMNatera, Inc. (NASDAQ:NTRA) Current Analyst Ratings - Fiscal Standard
07/20/16 08:29 AMNatera Inc on Focus After Raising In Today's Session - Consumer Eagle
07/20/16 08:29 AMEarnings Focus and Crowd Sourced Sentiment Review for Natera Inc (NASDAQ:NTRA) - TGP
07/18/16 07:15 AMNatera, Inc. breached its 50 day moving average in a Bullish Manner : NTRA-US : July 18, 2016 -
07/18/16 07:00 AMUnilabs Selects Natera, Inc.'s Panorama® Non-Invasive Prenatal Test (NIPT), Further Expanding Natera's Global Constellation™ Technology Transfer Business - [PR Newswire] - Constellation allows laboratories worldwide to access key technologies that Natera uses in its own lab, enabling them to develop, validate, and clinically offer complex, next generation clinical genomics testing from their own facilities. The licensing agreement also includes access to Natera's proprietary protocols, CE-marked (European Conforming) reagents, and algorithms within the Constellation software platform.
07/17/16 04:57 PMShare Performance Summary for: Natera, Inc. (NASDAQ:NTRA) - Press Telegraph
07/17/16 09:45 AMBroker Outlook For The Week Ahead Natera, Inc. (NASDAQ:NTRA) - Fiscal Standard
07/16/16 08:50 AMAnalyst Target and Average Rating Watch: Natera Inc (NASDAQ:NTRA) - Press Telegraph
07/16/16 08:50 AMShares Experiencing a Downtrend: Natera, Inc. (NASDAQ:NTRA) - TGP
07/15/16 10:26 AMNatera Inc (NASDAQ:NTRA) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 10:26 AMNatera Inc Realized Volatility Hits Extreme Level - CML News
07/14/16 09:08 AMStock Providing Gains on the Month for Investors: Natera, Inc. (NASDAQ:NTRA) - Telanagana Press
07/14/16 09:08 AMNatera Inc (NASDAQ:NTRA) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/11/16 10:09 AMNext Weeks Broker Price Targets For Natera, Inc. (NASDAQ:NTRA) - Fiscal Standard
07/11/16 10:09 AMStock Rating Watch and Earnings Insight for Natera Inc (NASDAQ:NTRA) - Press Telegraph
07/11/16 10:09 AMStock Performance Rundown on: Natera, Inc. (NASDAQ:NTRA) - Press Telegraph
07/09/16 08:46 AMCan Natera Inc (NASDAQ:NTRA) Improve on the Earnings Front? - Engelwood Daily
07/09/16 08:46 AMCompany Stock Focus for Natera Inc (NASDAQ:NTRA): Which Way Will Shares Head? - Press Telegraph
07/09/16 08:46 AMBroker Outlook For Natera, Inc. (NASDAQ:NTRA) - Fiscal Standard
07/07/16 05:33 PMStock Tracking Down This Month; Investor Alert on Natera, Inc. (NASDAQ:NTRA) - Engelwood Daily
07/07/16 05:33 PMWere Analysts Bearish Natera Inc (NASDAQ:NTRA) This Week? - Engelwood Daily
07/06/16 10:08 AMNatera Inc (NASDAQ:NTRA) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/03/16 04:55 PMCompany Stock Lower on the Week Natera, Inc. (NASDAQ:NTRA) - Engelwood Daily
07/02/16 05:12 PMNatera : Announces that the U.S. Supreme Court Denies Petition to Review ‘540 Patent Invalidation
07/01/16 08:21 AMRecently Issued Stock Ratings For Natera, Inc. (NASDAQ:NTRA) - Fiscal Standard
06/30/16 05:51 PMStock is down at $11.90 (NTRA) Natera Announces that the U.S. Supreme…
06/30/16 01:01 PMNatera Announces that the U.S. Supreme Court Denies Petition to Review '540 Patent Invalidation - [at noodls] - SAN CARLOS, Calif., June 30, 2016 /PRNewswire/ -- Natera (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, announced that the U.S. Supreme Court declined ...
06/30/16 08:24 AMNatera : and Illumina Extend Supply Agreement, Broaden Existing Partnership to Include Oncology Field
06/29/16 05:25 PMTime to Buy Natera Inc After Today's Huge Decline? - Press Telegraph
06/29/16 05:25 PMNatera Inc (NASDAQ:NTRA) Company Rating and Target Watch - Telanagana Press
06/28/16 05:28 PMCheck on Share Volatility: Natera, Inc. (NASDAQ:NTRA) - Engelwood Daily
06/27/16 09:44 AMShare Update and Earnings Review for Natera Inc (NASDAQ:NTRA) - Press Telegraph
06/27/16 09:44 AMNatera, Inc. (NASDAQ:NTRA) Broker Price Targets For The Coming Week - Fiscal Standard
06/24/16 05:28 PMThe Chemours Company (NYSE:CC) Surged 7.50%: Natera, Inc. (NASDAQ:NTRA), International Business Machines ... - KC Register
06/24/16 05:28 PMCovering the Bases on Natera Inc (NASDAQ:NTRA): Where is the Stock Going? - Press Telegraph
06/24/16 05:28 PMNatera Inc (NASDAQ:NTRA) Earnings Glance and Target Price Review - Engelwood Daily
06/24/16 05:28 PMNatera Inc (NTRA) CEO Matthew Rabinowitz Sold $8,75…,……… of Stocks - Nasdaq
06/24/16 04:41 PMETF’s with exposure to Natera, Inc. : June 24, 2016 -
06/23/16 06:02 PMNatera Inc (NTRA) CEO Matthew Rabinowitz Sold $8,750,000 of Stocks
06/23/16 05:36 PMNatera Inc (NTRA) CEO Matthew Rabinowitz Sold $8,75a,aaa of Stocks -
06/22/16 10:16 AMWednesday 6/22 Insider Buying Report: NTRA, NERV
06/14/16 03:28 PMNATERA, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Shee -
06/13/16 04:22 PMNATERA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Secur -
06/08/16 05:56 PMNATERA INC. (NASDAQ:NTRA) Financial Condition Compared to S&P 500 - CML News
06/04/16 08:23 AM1806 Shares of Natera Inc (NTRA) Stock are sold by Herm Rosenman - Let Me Know About This
06/03/16 05:59 PMNatera Inc (NTRA) Rating Reiterated by Cowen and Company - Let Me Know About This

Social

About Natera

Natera logoNatera, Inc. is a diagnostics company. The Company's product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening (Horizon) to determine carrier status for various severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening (PGS) and Spectrum Pre-implantation Genetic Diagnosis (PGD) to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization (IVF) cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father(s).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NTRA
  • CUSIP:
Key Metrics:
  • Previous Close: $13.10
  • 50 Day Moving Average: $12.40
  • 200 Day Moving Average: $10.23
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $671.45M
  • Current Year EPS Consensus Estimate: $-1.69 EPS
  • Next Year EPS Consensus Estimate: $-1.17 EPS
Additional Links:
Natera (NASDAQ:NTRA) Chart for Sunday, July, 31, 2016